首页> 美国卫生研究院文献>Journal of Tissue Engineering >Titanium phosphate glass microcarriers induce enhanced osteogenic cell proliferation and human mesenchymal stem cell protein expression
【2h】

Titanium phosphate glass microcarriers induce enhanced osteogenic cell proliferation and human mesenchymal stem cell protein expression

机译:磷酸钛玻璃微载体诱导增强的成骨细胞增殖和人类间充质干细胞蛋白表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this study, we have developed 50- to 100-µm-sized titanium phosphate glass microcarriers (denoted as Ti5) that show enhanced proliferation of human mesenchymal stem cells and MG63 osteosarcoma cells, as well as enhanced human mesenchymal stem cell expression of bone differentiation markers, in comparison with commercially available glass microspheres at all time points. We also demonstrate that these microcarriers provide superior human mesenchymal stem cell proliferation with conventional Dulbecco’s Modified Eagle medium than with a specially developed commercial stem cell medium. The microcarrier proliferative capacity is revealed by a 24-fold increase in MG63 cell numbers in spinner flask bioreactor studies performed over a 7-day period, versus only a 6-fold increase in control microspheres under the same conditions; the corresponding values of Ti5 and control microspheres under static culture are 8-fold and 7-fold, respectively. The capability of guided osteogenic differentiation is confirmed by ELISAs for bone morphogenetic protein-2 and osteopontin, which reveal significantly greater expression of these markers, especially osteopontin, by human mesenchymal stem cells on the Ti5 microspheres than on the control. Scanning electron microscopy and confocal laser scanning microscopy images reveal favorable MG63 and human mesenchymal stem cell adhesion on the Ti5 microsphere surfaces. Thus, the results demonstrate the suitability of the developed microspheres for use as microcarriers in bone tissue engineering applications.
机译:在这项研究中,我们开发了50至100 µm大小的磷酸钛玻璃微载体(表示为Ti5),显示出人间充质干细胞和MG63骨肉瘤细胞的增殖增强,以及人间充质干细胞的骨分化表达增强与市面上所有玻璃微球在所有时间点的标记相比。我们还证明,与专门开发的商业干细胞培养基相比,传统的Dulbecco改良版Eagle培养基与传统的商业干细胞培养基相比,这些微载体可提供优异的人间充质干细胞增殖能力。在7天的时间进行的旋转瓶生物反应器研究中,MG63细胞数量增加了24倍,而在相同条件下对照微球仅增加了6倍,从而揭示了微载体的增殖能力。在静态培养下,Ti5和对照微球的对应值分别为8倍和7倍。 ELISA证实了骨形态发生蛋白2和骨桥蛋白的引导性成骨分化能力,与人相比,它们在Ti5微球上的人间充质干细胞显着提高了这些标志物(尤其是骨桥蛋白)的表达。扫描电子显微镜和共聚焦激光扫描显微镜图像显示,Ti63微球表面上MG63和人间充质干细胞具有良好的粘附性。因此,结果证明了开发的微球在骨组织工程应用中用作微载体的适用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号